Experience

Noramco™

• United States
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Senior Analytical Scientist

  • Aug 2019 - Present

  Analysis from proof of concept, bench chemistry samples to full-scale commercialized products in compliance with US FDA cGMPs and other global regulatory bodies.

• Analytical Scientist

  • Sep 2017 - Jul 2019



Merial

• Germany
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Analytical Scientist

  • Mar 2015 - Aug 2017

  Characterization of virus and protein-based vaccine products by HPLC assays 1. Analyze research samples by Ion Exchange (IEX) and Size Exclusion Chromatography (SEC) 2. Optimize existing HPLC methods to measure total virus particles in products 3. Develop new HPLC assays for protein-based vaccines 4. Validate analytical protocols, document test procedures, and complete technical reports 5. Coordinate with Process Development and Clinical groups in a GLP/GMP-like environment Characterization of virus and protein-based vaccine products by HPLC assays 1. Analyze research samples by Ion Exchange (IEX) and Size Exclusion Chromatography (SEC) 2. Optimize existing HPLC methods to measure total virus particles in products 3. Develop new HPLC assays for protein-based vaccines 4. Validate analytical protocols, document test procedures, and complete technical reports 5. Coordinate with Process Development and Clinical groups in a GLP/GMP-like environment



The University of Georgia

• Higher Education
• 700 & Above Employee

• Research Fellow

  • Apr 2014 - Feb 2015

  Synthesis of enzyme-polymer conjugates with improved thermal stability Synthesis of enzyme-polymer conjugates with improved thermal stability



MedImmune

• United States
• Biotechnology Research
• 700 & Above Employee

• Scientist I

  • Mar 2011 - Mar 2014

  Development of antibody-drug conjugates and antibody-based molecular imaging probes 1. Evaluate the aggregation and labeling of antibody-drug conjugates by HPLC a. Assess ADC aggregation percentage by SEC b. Analyze the drug loading-distribution of ADCs by Hydrophobic Interaction Chromatography (HIC) 2. Characterize the toxicity of antibody-drug conjugates by cell-based potency assays 3. Investigate the binding affinities of ADC conjugates to tumor cells by flow… Show more Development of antibody-drug conjugates and antibody-based molecular imaging probes 1. Evaluate the aggregation and labeling of antibody-drug conjugates by HPLC a. Assess ADC aggregation percentage by SEC b. Analyze the drug loading-distribution of ADCs by Hydrophobic Interaction Chromatography (HIC) 2. Characterize the toxicity of antibody-drug conjugates by cell-based potency assays 3. Investigate the binding affinities of ADC conjugates to tumor cells by flow cytometry Show less Development of antibody-drug conjugates and antibody-based molecular imaging probes 1. Evaluate the aggregation and labeling of antibody-drug conjugates by HPLC a. Assess ADC aggregation percentage by SEC b. Analyze the drug loading-distribution of ADCs by Hydrophobic Interaction Chromatography (HIC) 2. Characterize the toxicity of antibody-drug conjugates by cell-based potency assays 3. Investigate the binding affinities of ADC conjugates to tumor cells by flow… Show more Development of antibody-drug conjugates and antibody-based molecular imaging probes 1. Evaluate the aggregation and labeling of antibody-drug conjugates by HPLC a. Assess ADC aggregation percentage by SEC b. Analyze the drug loading-distribution of ADCs by Hydrophobic Interaction Chromatography (HIC) 2. Characterize the toxicity of antibody-drug conjugates by cell-based potency assays 3. Investigate the binding affinities of ADC conjugates to tumor cells by flow cytometry Show less



The National Institutes of Health

• United States
• Biotechnology Research
• 700 & Above Employee

• Research Fellow

  • Aug 2009 - Mar 2011

  Site-specific protein labeling and bioconjugation; Developing protein-based probes for angiogenesis and apoptosis imaging Site-specific protein labeling and bioconjugation; Developing protein-based probes for angiogenesis and apoptosis imaging



Stanford University

• United States
• Higher Education
• 700 & Above Employee

• Postdoc

  • 2009 - 2009

  Protein-based probes for angiogenesis imaging Protein-based probes for angiogenesis imaging